K
Konstantinos Koutsampasopoulos
Researcher at Aristotle University of Thessaloniki
Publications - 22
Citations - 165
Konstantinos Koutsampasopoulos is an academic researcher from Aristotle University of Thessaloniki. The author has contributed to research in topics: Internal medicine & Medicine. The author has an hindex of 4, co-authored 13 publications receiving 52 citations.
Papers
More filters
Journal ArticleDOI
Macrovascular Complications of Type 2 Diabetes Mellitus.
Margus Viigimaa,Alexandros Sachinidis,Maria Toumpourleka,Konstantinos Koutsampasopoulos,Signe Alliksoo,Tiina Titma +5 more
TL;DR: T2DM causes a variety of macrovascular complications through different pathogenetic pathways that include hyperglycaemia and insulin resistance, which need more clinical studies in order to identify the pure effect of T2DM.
Journal ArticleDOI
Glycemic efficacy and safety of glucagon-like peptide-1 receptor agonist on top of sodium-glucose co-transporter-2 inhibitor treatment compared to sodium-glucose co-transporter-2 inhibitor alone: A systematic review and meta-analysis of randomized controlled trials.
Dimitrios Patoulias,Konstantinos Stavropoulos,Konstantinos Imprialos,Alexandra Katsimardou,Maria-Styliani Kalogirou,Konstantinos Koutsampasopoulos,Ioanna Zografou,Christodoulos Papadopoulos,Asterios Karagiannis,Michael Doumas +9 more
TL;DR: This meta-analysis suggests that a GLP-1RA/SGLT-2i combination, if tolerated, exerts significant beneficial effects on glycemic control and body weight loss, however increasing the risk for any hypoglycemia and gastrointestinal adverse events is suggested.
Journal ArticleDOI
Erectile Dysfunction as a Cardiovascular Risk Factor: Time to Step Up?
TL;DR: Accumulating evidence supports a strong predictive role of ED for CV events, and Phosphodiesterase type 5 inhibitors were shown to be safe in terms of CV events in patients with and without CV disease.
Journal ArticleDOI
Role of PCSK9 Inhibitors in High Risk Patients with Dyslipidemia: Focus on Familial Hypercholesterolemia.
Vasilios Papademetriou,Konstantinos Stavropoulos,Christodoulos Papadopoulos,Konstantinos Koutsampasopoulos,Kiriakos Dimitriadis,Kostas Tsioufis +5 more
TL;DR: Available evidence suggests similar potency of alirocumab and evolocumab in reducing lipids and CV events, and other mild differences observed in the CV trials of these drugs.
Journal ArticleDOI
Right Ventricular Function and Sexual Function: Exploring Shadows in Male and Female Patients With Heart Failure.
Konstantinos Koutsampasopoulos,Ioannis Vogiatzis,Antonios Ziakas,Christodoulos Papadopoulos,Konstantinos Imprialos,Konstantinos Stavropoulos,Konstantinos Stavropoulos,Alexandra Katsimardou,Dimitrios Patoulias,Constantinos Bakogiannis,Vasilios Vasilikos,Asterios Karagiannis,Michael Doumas,Michael Doumas +13 more
TL;DR: Right ventricular dysfunction in patients with HF reflects an impaired sexual function status, and potential interventions to improve sexual and right ventricular function and prognosis in this population are suggested.